首页> Infectious diseases (London, England)> Adequacy of initiating TNF antagonists within 3 weeks of starting latent tuberculosis infection treatment in patients with immune-mediated inflammatory diseases.

Adequacy of initiating TNF antagonists within 3 weeks of starting latent tuberculosis infection treatment in patients with immune-mediated inflammatory diseases.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ji-Young,Yang

第一单位： a Division of Pulmonary and Critical Care Medicine , University of Ulsan College of Medicine, Asan Medical Center , Seoul , South Korea.

作者： Ji-Young,Yang ^[1] ; Kyung-Wook,Jo ^[1] ; Seokchan,Hong ^[2] ; Bin,Yoo ^[2] ; Chang-Keun,Lee ^[2] ; Yong-Gil,Kim ^[2] ; Suk-Kyun,Yang ^[3] ; Jeong-Sik,Byeon ^[3] ; Kyung-Jo,Kim ^[3] ; Byong Duk,Ye ^[3] ; Sang-Hyoung,Park ^[3] ; Tae Sun,Shim ^[1]

作者单位： a Division of Pulmonary and Critical Care Medicine , University of Ulsan College of Medicine, Asan Medical Center , Seoul , South Korea. ^[1] b Division of Rheumatology , University of Ulsan College of Medicine, Asan Medical Center , Seoul , South Korea. ^[2] c Division of Gastroenterology , University of Ulsan College of Medicine, Asan Medical Center , Seoul , South Korea. ^[3]

关键词 3 weeks Latent tuberculosis infection tumour necrosis factor